Business Context and Reporting Period
This Form 8-K reports the results of the annual meeting of stockholders for NSTS Bancorp, Inc., held on May 21, 2025. The company is incorporated in Delaware and its common stock trades on the NASDAQ Capital Market under the symbol NSTS.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
A total of 3,905,249 shares were present or represented by proxy, representing 74.42% of outstanding shares entitled to vote. Three proposals were voted upon:
- Proposal 1: Election of Directors. Two nominees were elected to three-year terms expiring in 2028:
- Emily E. Ansani: 2,007,872 votes FOR; 955,763 votes WITHHELD.
- Thomas M. Ivantic: 1,926,437 votes FOR; 1,037,198 votes WITHHELD.
- Proposal 2: Ratification of Auditors. The appointment of Plante & Moran, PLLC as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified.
- FOR: 3,765,451
- AGAINST: 101,075
- ABSTAIN: 38,723
- Proposal 3: Stockholder Proposal to Sell or Merge. A non-binding proposal recommending the sale or merger of the Company was voted upon.
- FOR: 1,564,131
- AGAINST: 531,187
- ABSTAIN: 838,300
- BROKER NON-VOTES: 971,631
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, management outlook, specific risks, or contingencies beyond the standard disclosure of the voting results.
Important Facts for Investors to Verify
- Verify the final outcome of the non-binding Proposal 3 regarding the sale or merger, noting the significant number of broker non-votes (971,631) and abstentions (838,300) relative to the "For" votes.
- Confirm the specific terms of the three-year director terms for Emily E. Ansani and Thomas M. Ivantic as detailed in the 2025 Proxy Statement.
- Review the 2025 Proxy Statement for detailed background on the stockholder proposal to sell or merge the company.